Zdrowie i gospodarka · 19/03/2015

FDA Hosts Public Workshop to Discuss Clinical Considerations of Risk in Postmarket Environment, Seeks Comments on Proposed Guidance

The US Food and Drug Administration (FDA) is hosting a public workshop to discuss the clinical considerations of risk in the postmarket environment, and is seeking comments on proposed guidance to help ensure the safe use of medical devices and pharmaceuticals after they have been approved and are on the market.